Get the Stockscreener App
35.54
5.15%
1.74
Bruker Corp stock is traded at $35.54, with a volume of 1.94M.
It is up +5.15% in the last 24 hours and down -8.40% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$33.80
Open:
$34.01
24h Volume:
1.94M
Relative Volume:
0.70
Market Cap:
$5.39B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
17.09
EPS:
2.08
Net Cash Flow:
$156.70M
1W Performance:
+6.03%
1M Performance:
-8.40%
6M Performance:
-30.07%
1Y Performance:
-44.21%
1-Day Range:
$34.01
$35.86
1-Week Range:
$33.06
$35.86
52-Week Range:
$30.00
$72.94
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
35.54 | 5.19B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker acquires Austria based biocrates - MSN
Bruker plans to file for a stay of NanoString GeoMX injunction ruling - MSN
Comparing Bruker Corporation in custom built stock radarsJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - Newser
Published on: 2025-08-15 21:28:58 - Newser
Technical signs of recovery in Bruker CorporationGlobal Markets & Real-Time Stock Entry Alerts - Newser
What’s the recovery path for long term holders of Bruker CorporationEarnings Overview Summary & Momentum Based Trading Signals - Newser
Leading vs lagging indicators on Bruker Corporation performanceWeekly Trade Analysis & Proven Capital Preservation Tips - Newser
Bruker's Strategic Reengineering: Navigating ACA/GOV Headwinds to Unlock Margin Expansion - AInvest
Scion Asset Management Discloses Q2 Holdings: New Buys, Reduced Stake in Estee Lauder. - AInvest
Candlestick Signal Suggests Reversal in Bruker CorporationWeekly Stock Report & Short-Term Trading Alerts - newsimpact.co.kr
Clover Health, Surgery Partners, Illumina, Bruker, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know - ca.finance.yahoo.com
US Bancorp DE Buys 480 Shares of Bruker Corporation (NASDAQ:BRKR) - Defense World
5 Must-Read Analyst Questions From Bruker’s Q2 Earnings Call - Yahoo Finance
Is Bruker Corporation stock risky to hold nowJuly 2025 PostEarnings & Comprehensive Market Scan Insights - thegnnews.com
10X Genomics Q2 Earnings Call Highlights: Balancing Growth and Challenges with Strong China Performance and Favorable Bruker Settlement - AInvest
Bruker Corp To Go Ex-Dividend On September 23rd, 2025 With 0.05 USD Dividend Per Share - 富途牛牛
Bruker Announces Quarterly Cash Dividend of $0.05 per Share. - AInvest
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker Maintains Quarterly Dividend of $0.05 per Share, Payable Oct. 3 to Holders of Record as of Sept. 23 - MarketScreener
Bruker to pay $0.05 quarterly dividend in October By Investing.com - Investing.com Canada
Bruker to pay $0.05 quarterly dividend in October - Investing.com
Bruker Announces Quarterly Dividend - Stock Titan
PNC Financial Services Group Inc. Has $728,000 Stock Position in Bruker Corporation (NASDAQ:BRKR) - Defense World
Bruker's Q2 Earnings Miss Estimates, Stock Tumbles, Margins Contract - Nasdaq
Bruker Secures Multi-Year Contracts for Explosives and Chemical Trace Detection in Aviation and Defense Sectors - The Globe and Mail
Why Investors Shouldn't Be Surprised By Bruker Corporation's (NASDAQ:BRKR) 31% Share Price Plunge - simplywall.st
Bruker Corporation (BRKR): A Bull Case Theory - MSN
` - Insider Monkey
Bruker Corp. (BRKR) Faces Funding Challenges, But Long-Term Fundamentals Remain Intact. - AInvest
Bruker Corp. (BRKR) Sheds 8.6% on Dismal Earnings, Outlook - MSN
Investors Don't See Light At End Of Bruker Corporation's (NASDAQ:BRKR) Tunnel And Push Stock Down 26% - 富途牛牛
Wells Fargo Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
Unlocking Bruker (BRKR) International Revenues: Trends, Surprises, and Prospects - Yahoo Finance
Bruker Corporation shares rise 1.11% premarket after securing multi-year contracts for explosives and chemical trace detection solutions. - AInvest
Bruker Corporation Earnings Miss: Revenue Growth Expected to Slow Down in 2025 - AInvest
Earnings Miss: Bruker Corporation Missed EPS By 38% And Analysts Are Revising Their Forecasts - Yahoo Finance
Bruker Bets On Science, But Debt And Margins Weigh Heavy - Finimize
Beyond the Balance Sheet: What SWOT Reveals About Bruker Corp (B - GuruFocus
Bruker Corporation (NASDAQ:BRKR) Q2 2025 Earnings Call Transcript - Insider Monkey
Bruker Secures Contracts for Explosives, Chemical Trace Detection - MarketScreener
Bruker Corp secures multi-year contracts for trace detection - MarketScreener
BRUKER CORP SEC 10-Q Report - TradingView
Bruker's Strategic Cost-Saving Initiatives and Margin Expansion Justify Buy Rating Amid Market Challenges - AInvest
These Analysts Slash Their Forecasts On Bruker After Weaker-Than-Expected Q2 ResultsBruker (NASDAQ:BRKR) - Benzinga
Bruker stock price target lowered to $40 by TD Cowen on weak demand - Investing.com
J.P. Morgan Maintains Bruker Corp(BRKR.US) With Buy Rating, Announces Target Price $50 - 富途牛牛
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $38 to $60 - 富途牛牛
Stifel lowers Bruker stock price target to $40 on weak academic spending - Investing.com Canada
JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating - Investing.com
JPMorgan lowers Bruker stock price target to $50 from $60, maintains Overweight rating By Investing.com - Investing.com South Africa
Bruker Stock: Caution Warranted Despite Bullish Analyst Calls - 富途牛牛
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bruker Corp Stock (BRKR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ORNELL JOHN A | Director |
May 13 '25 |
Option Exercise |
18.15 |
5,000 |
90,750 |
31,445 |
| LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
| Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):